metabolic effects [phsf]
Drospirenone + estradiol [orch, phsu]
Menopausal [phsf]
Women [popg]
Study, Prospective [resa]
objectives [inpr]
effects [qlco]
Low dose [qnco]
therapy, hormonal [topp]
Replacement [topp]
Quality [qlco]
Life [idcn]
Metabolic [ftcn]
Parameters [fndg]
Blood Pressure [orgf]
postmenopausal [tmco]
Women [popg]
Methods [inpr]
postmenopausal [tmco]
Women [popg]
untreated [fndg]
therapy, hormonal [topp]
Replacement [topp]
Sex [orgf]
Steroids [strd]
Previous [tmco]
months [tmco]
randomized [resa]
treatment [ftcn]
17 beta-Estradiol [horm, phsu, strd]
1 Day [tmco]
mg% [qnco]
Plus [qlco]
drospirenone [orch, phsu]
mg day [qnco]
E2 [gngm]
Calcium [bacs, elii, phsu]
Quality [qlco]
Life [idcn]
Evaluated [ftcn]
Questionnaire [inpr]
baseline [bodm]
weeks [tmco]
treatment [ftcn]
Anthropometry [resa]
Metabolic [ftcn]
Blood Pressure [orgf]
measurements [ftcn]
Performed [ftcn]
3 Months [tmco]
treatment [ftcn]
Domain [ftcn]
Score [qnco]
Vasomotor [ftcn]
Somatic [qlco]
symptoms [ftcn]
anxiety fear [mobd]
Depressed Mood [mobd]
Sexual Behavior [bhvr]
Sleep problem [dsyn]
Decreased [qnco]
E2 [gngm]
Group [idcn]
Relative [famg]
baseline [bodm]
Values [qlco]
P NOS [aapp, imft]
Body Mass Index [diap]
Unchanged [fndg]
Waist Circumference [clna]
Decreased [qnco]
P NOS [aapp, imft]
E2 [gngm]
treatment [ftcn]
decreases [qnco]
Observed [ftcn]
E2 [gngm]
treatment [ftcn]
blood insulin [lbpr]
Values [qlco]
Insulin Resistance [patf]
Estimated [qnco]
Homeostasis model assessment [lbpr]
Systolic blood pressure [clna]
P NOS [aapp, imft]
Subject [grup]
Systolic blood pressure [clna]
mmHg [qnco]
baseline [bodm]
Systolic [tmco]
Values [qlco]
Registered [hlca]
Women [popg]
baseline [bodm]
high systolic blood pressure [fndg]
Normal [qlco]
mmHg [qnco]
decreases [qnco]
P NOS [aapp, imft]
E2 [gngm]
MODIFY [ftcn]
Diastolic blood pressure [clna]
Values [qlco]
Calcium [bacs, elii, phsu]
treatment [ftcn]
Group [idcn]
Scores [qnco]
Anthropometry [resa]
Metabolic [ftcn]
Blood Pressure [orgf]
measurements [ftcn]
postmenopausal [tmco]
Women [popg]
E2 [gngm]
Administration [ocac]
vasomotor symptom [sosy]
General [spco]
Aspect [qnco]
Quality [qlco]
Life [idcn]
cardiovascular risk factor [dsyn]
